Venmax Drugs and Pharmaceuticals

Name

Venmax Drugs and Pharmaceuticals

Legal name

Venmax Drugs & Pharmaceuticals Ltd

Website

https://venmaxdrugs.com

Company type

Public

Founded year

1988

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Headquarters

HQ city

Hyderabad

HQ country

India

HQ region

Asia

Offices3 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Pharmaceutical Products: The company manufactures and sells pharmaceutical products, operating retail medical stores under the Ananya Pharma brand. The business model involves both wholesale formulation supply from Suzichem Labs and retail pharmacy operations.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

Venmax Drugs & Pharmaceuticals Ltd (VDPL) is a publicly listed Indian pharmaceutical company that operates the "Ananya Pharma" retail pharmacy chain in and around Hyderabad, dispensing pharmaceutical products sourced from Suzichem Labs formulations plant. The company has three operational Ananya Pharma stores with plans to expand to 50 locations. It is also developing oncology pharmaceutical products in R&D and is planning to establish a cGMP-certified manufacturing facility at the Hyderabad Pharma Cluster to meet export demand.

Product overview

Venmax Drugs & Pharmaceuticals Ltd (VDPL) is a pharmaceutical company that operates a single unified business model centered around its retail pharmacy brand 'Ananya Pharma'. The company has established three medical retail stores under this brand with plans to expand to 50 stores. The company is also developing oncology products in R&D and planning to establish a manufacturing unit with cGMP facility for export demand. VDPL was incorporated in 1998 and has undergone multiple name changes before becoming Venmax Drugs & Pharmaceuticals Ltd in 2009.

Differentiator

Problem solved

Functional benefit

Products and services

• Ananya Pharma Retail Pharmacy Chain

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Four partnerships are on record, tiered core and minor.

• Suzichem LabscoreOthersSuzichem Labs provides formulations (finished pharmaceutical products) that support the Ananya Pharma retail pharmacy chain operated by Venmax Drugs & Pharmaceuticals Ltd.
• PPKG & CominorOthersPPKG & Co, Chartered Accountants, Hyderabad serves as the Statutory Auditor for Venmax Drugs & Pharmaceuticals Ltd.
• Kashinath Sahu & CominorOthersKashinath Sahu & Co, Practising Company Secretaries, Hyderabad serves as the Secretarial Auditor for Venmax Drugs & Pharmaceuticals Ltd.
• CIL Securities LtdminorOthersCIL Securities Ltd acts as the Registrar & Share Transfer Agent for Venmax Drugs & Pharmaceuticals Ltd, handling investor share transfers and registry services.

Scale indicators5 records

Recent moves9 records

Expansion highlights5 records

Direct peers

• Tata 1mg: Digital pharmacy and retail platform in India (Tata-owned), serving consumers with medicines and diagnostics. Comparable as a competing retail distribution model targeting Indian pharma consumers.
• MedPlus Health Services: India's largest organized pharmacy retail chain with thousands of stores nationwide. Directly comparable to Venmax's Ananya Pharma retail pharmacy model and expansion strategy in Indian metro/Tier-2 markets.
• Apollo Pharmacy: Retail pharmacy chain operated by Apollo Hospitals, with deep penetration across India. Comparable as a direct retail pharmacy peer pursuing scale-led distribution of pharmaceutical products to end consumers.

Others

• Suzichem Labs: Formulation partner providing pharmaceutical products backing Ananya Pharma retail stores. Listed as 'core' strategic partnership; relevant as a closely-linked ecosystem participant whose continuity is critical to VDPL's retail operations.

Broad incumbents

• Cipla: Major Indian generic and specialty pharmaceutical manufacturer with global presence including oncology. Comparable as a broad incumbent in the same Indian pharma ecosystem with far greater scale in formulation development and exports.
• Natco Pharma: Indian specialty pharmaceutical company with strong oncology generics franchise and export orientation. Comparable as a larger, established Indian pharma with oncology development and manufacturing capabilities that VDPL aspires to build.
• Aurobindo Pharma: Major Indian generic pharmaceutical manufacturer with extensive global footprint. Comparable as a broad incumbent operating in the same Hyderabad pharma ecosystem with manufacturing and export scale.
• Dr. Reddy's Laboratories: Large Indian pharmaceutical company with significant generics, API, and biosimilars operations including oncology. Comparable as a broad incumbent in pharmaceutical manufacturing and export that dwarf VDPL's planned ambitions.

Emerging players

• SMS Pharmaceuticals: Indian small/mid-cap pharmaceutical company focused on APIs and formulations. Comparable as a Hyderabad-based pharma company at a similar scale and stage, providing a more size-comparable Indian pharma reference point.
• Suven Life Sciences: Indian pharmaceutical company focused on niche specialty and CNS products with export orientation. Comparable as a similarly-sized Indian pharma pursuing specialty formulations for global markets.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights5 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Venmax Drugs and Pharmaceuticals